The Epilepsy Network (TEN) / News / New Approach for the Treatment of Epilepsy Authorized by Health Canada – FYCOMPA(TM) (perampanel) is Now Available as an Adjunctive Treatment for Adult Patients
Eisai Limited is pleased to announce the Health Canada authorization and availability of FYCOMPA (perampanel) indicated as an adjunctive therapy in the management of partial-onset seizures, in adult patients with epilepsy who are not satisfactorily controlled with conventional therapy.
FYCOMPA is a first-in-class treatment authorized by Health Canada that selectively and non-competitively targets post-synaptic AMPA glutamate receptors, representing a new approach to seizure control.
The Epilepsy Network is a worldwide community of people with epilepsy, family and friends, uniting to talk about their experiences, learn information about epilepsy, ask questions and so much more! Don’t let epilepsy defeat you, let it inspire you!
